Regulation of mutant TERT by BRAF V600E/MAP kinase pathway through FOS/GABP in human cancer
Rengyun Liu(Sun Yat-sen University), Mingzhao Xing(Johns Hopkins University)
Cited by 179
Related Papers
BRAF mutation in thyroid cancer
|Endocrine Related Cancer|2005|1.3k
BRAF Mutation in Papillary Thyroid Cancer: Pathogenic Role, Molecular Bases, and Clinical Implications
|Endocrine Reviews|2007|986
JAK/STAT3 signaling is required for TGF-β-induced epithelial-mesenchymal transition in lung cancer cells
|International Journal of Oncology|2014|308
BRAF V600E Maintains Proliferation, Transformation, and Tumorigenicity of BRAF-Mutant Papillary Thyroid Cancer Cells
|The Journal of Clinical Endocrinology & Metabolism|2007|124
The Akt-Specific Inhibitor MK2206 Selectively Inhibits Thyroid Cancer Cells Harboring Mutations That Can Activate the PI3K/Akt Pathway
|The Journal of Clinical Endocrinology & Metabolism|2011|105